BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9730152)

  • 1. Low-dose cisplatin-5-fluorouracil prevents postoperative suppression of natural killer cell activity in patients with gastrointestinal cancer.
    Ishikawa K; Shimoda K; Shiraishi N; Adachi Y; Kitano S
    Jpn J Clin Oncol; 1998 Jun; 28(6):374-7. PubMed ID: 9730152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer].
    Okabo S; Arai T; Maruyama S; Lee M; Murase N; Tsubaki M; Endo M; Wada Y; Shimoju K; Sakurazawa K; Sugihara K; Maruyama M; Yabata E; Kawasaki T; Sasaki T
    Gan To Kagaku Ryoho; 1997 May; 24(7):849-54. PubMed ID: 9170524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma.
    Colorectal Cancer Chemotherapy Study Group of Japan - The 2nd Trial
    Jpn J Clin Oncol; 2003 Jun; 33(6):288-96. PubMed ID: 12913083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-hepato-arterial chemotherapy with CDDP and 5-FU for metastases to the liver from colorectal and gastric cancers.
    Maeta M; Koga S; Shimizu N; Hamazoe R; Murakami A; Ishiguro M; Sawada T
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1199-203. PubMed ID: 3416904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
    Matzinger O; Roelofsen F; Mineur L; Koswig S; Van Der Steen-Banasik EM; Van Houtte P; Haustermans K; Radosevic-Jelic L; Mueller RP; Maingon P; Collette L; Bosset JF;
    Eur J Cancer; 2009 Nov; 45(16):2782-91. PubMed ID: 19643599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three successful case reports of advanced gastric cancer with chemotherapy].
    Yamamoto M; Niinobu T; Taniguchi H; Kotobuki T; Fukunaga K; Kawai M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1689-92. PubMed ID: 15553684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Oyama R; Ogata Y
    Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of continuous infusion of 5-fluorouracil and daily low-dose cisplatin for inoperable recurrent cancer of the stomach and colon].
    Satoh Y; Une Y; Fujisawa J; Sawaguchi Y; Muranaga S; Obara M; Uchino J
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):87-92. PubMed ID: 7826083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer.
    Imada T; Sairenji M; Suda T; Yamamoto Y; Amano T; Motohashi H
    Hepatogastroenterology; 1999; 46(25):594-600. PubMed ID: 10228867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
    Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
    Murata S; Yamamoto H; Shimizu T; Naitoh H; Yamaguchi T; Kaida S; Takebayashi K; Miyake T; Tani T; Tani M
    J Surg Oncol; 2018 Mar; 117(4):671-677. PubMed ID: 29266509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].
    Shirasaka T; Yamamitsu S; Tsuji A; Terashima M; Hirata K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):832-45. PubMed ID: 10897209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of cisplatin and intensive course 5-fluorouracil for the treatment of advanced colorectal cancer.
    O'Connell MJ; Moertel CG; Kvols LK; Hahn RG; Rubin J
    Am J Clin Oncol; 1986 Jun; 9(3):192-5. PubMed ID: 3524189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience of intermittent administration of 5-FU and CDDP to patients with advanced and recurrent gastric cancer].
    Sekikawa K; Anzai K; Ishihata R; Yamaki T; Ohki S; Kimijima I; Takenoshita S
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):825-8. PubMed ID: 11432352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.
    Kemeny N; Israel K; Niedzwiecki D; Chapman D; Botet J; Minsky B; Vinciguerra V; Rosenbluth R; Bosselli B; Cochran C
    J Clin Oncol; 1990 Feb; 8(2):313-8. PubMed ID: 2405107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-dose FP therapy for advanced and recurrent gastric cancer].
    Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.